Live feed06:00:00·15dPRReleasevia QuantisnowAnnexon Expands Vonaprument Phase 3 Program in Geographic Atrophy with Addition of Month 24 Dual Primary Endpoint Complementing Month 15 Primary Endpoint and Launch of Open-Label Extension StudyByQuantisnow·Wall Street's wire, on your screen.ANNX· Annexon Inc.Health Care
